Stages

Stage describes how much cancer there is and how far it has spread. For soft tissue sarcoma, stages generally range from 1 to 4. A lower stage generally means the cancer is more limited. A higher stage means it is more advanced.

Both tumor grade and stage help the healthcare team understand the likely outcome of the condition, called the prognosis, and decide the treatment plan.

Healthcare professionals usually summarize the stage as TNM plus grade. TNM stands for:

  • T: The size and extent of the primary tumor.
  • N: Whether the cancer has spread to nearby lymph nodes.
  • M: Whether the cancer has spread to distant parts of the body.
  • Grade: The grade of the tumor.

Separate staging criteria are used for sarcomas in different areas of the body. Some soft tissue sarcomas do not have staging.

Your care team can explain how your soft tissue sarcoma's stage is described and what that means for you.

Dec. 04, 2024

Living with sarcoma de tejido blando?

Connect with others like you for support and answers to your questions in the Sarcoma support group on Mayo Clinic Connect, a patient community.

Sarcoma Discussions

citizendeveloper
FS-DFSP (Fibrosarcomatous dermatofibrosarcoma): Anyone else?

56 Replies Thu, Sep 10, 2026

Colleen Young, Connect Director
Diagnosed with sarcoma? Let's share

1103 Replies Wed, Sep 09, 2026

lessjudd1976
What treatments did you have for angiosarcoma?

10 Replies Tue, Sep 01, 2026

See more discussions
  1. Townsend CM Jr, et al. Soft tissue sarcoma. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Feb. 23, 2023.
  2. Soft tissue sarcoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1464. Accessed Sept. 26, 2022.
  3. Goldman L, et al., eds. Malignant tumors of bone, sarcomas, and other soft tissue neoplasms. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 19, 2023.
  4. Goldblum JR, et al., eds. Enzinger and Weiss's Soft Tissue Tumors. 7th ed. https://www.clinicalkey.com. Accessed March 5, 2023.
  5. Niederhuber JE, et al., eds. Sarcomas of soft tissue. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Sept. 26, 2022.
  6. Soft tissue sarcoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq. Accessed Feb. 19, 2023.
  7. Childhood soft tissue sarcoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-soft-tissue-treatment-pdq. Accessed Feb. 19, 2023.
  8. Taking time: Support for people with cancer. National Cancer Institute. https://www.cancer.gov/publications/patient-education/taking-time. Accessed Feb. 19, 2023.
  9. Gamboa AC, et al. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine. CA: A Cancer Journal for Clinicians. 2020; doi:10.3322/caac.21605.
  10. Ami TR. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 5, 2023.
  11. Sarcoma centers. Sarcoma Alliance. https://sarcomaalliance.org/sarcoma-centers/. Accessed Feb. 17, 2023.
  12. SARC clinical trials. Sarcoma Alliance for Research through Collaboration. https://sarctrials.org/research/sarc-clinical-trials/. Accessed Feb. 19, 2023.
  13. Salerno KE, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: Executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncology. 2021; doi:10.1016/j.prro.2021.04.005.
  14. Brinkmann EJ, et al. Extremity soft tissue sarcoma: Role of local control. Current Treatment Options in Oncology. 2020; doi:10.1007/s11864-020-0703-9.